This category highlights modern approaches for generating antibodies. It covers various screening technologies, pipeline strategies, and updates that benefit research and clinical applications.
Discover fully human antibodies faster with AbDrop™ & HUGO-Ab™. Our high-throughput platform combines microfluidics and TurboKnockout® in just 3 months.
Learn how TCR-like antibodies target intracellular tumor antigens through pMHC recognition. Explore their role, development, and potential in immunotherapy.
Explore CAR-T cell therapy innovations, antibody discovery, and engineering advancements to improve targeting, safety, and treatment efficacy in cancer immunotherapy.
Explore cutting-edge antibody discovery technologies and trends—hybridoma, phage display, single B cell tech, and AI innovations in driving therapeutic breakthroughs.
Explore how computational predictors like SCM, TAP, and AlphaFold support therapeutic antibody development through AI-driven workflows and in silico tools.
You can also contact us on the Scientist and Science Exchange marketplaces.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
